Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Cancer Medicine|December 2, 2021
A functional methylation signature to predict the prognosis of Chinese lung adenocarcinoma based on TCGAKe Wang, Ying Liu, Guanzhong Lu, et al.
Plos One|December 11, 2012
TERT-CLPTM1L polymorphism rs401681 contributes to cancers risk: evidence from a meta-analysis based on 29 publicationsJieyun Yin, Yangkai Li, Ming Yin, et al.
Cancer Letters|September 13, 2020
Loss of histone lysine methyltransferase EZH2 confers resistance to tyrosine kinase inhibitors in non-small cell lung cancerChuntao Quan, Yuchen Chen, Xiaomu Wang, et al.
Cancer Medicine|May 3, 2021
DNA methylome analysis identifies BMI-related epigenetic changes associated with non-small cell lung cancer susceptibilityGuyanan Li, Hua Meng, Yansen Bai, et al.
European Journal of Cancer (Oxford, England : 1990)|December 4, 2013
Functional single nucleotide polymorphisms of the RASSF3 gene and susceptibility to squamous cell carcinoma of the head and neckHongguang Guo, Hongliang Liu, Jianhua Wei, et al.
Ecotoxicology and Environmental Safety|April 5, 2025
Plasma tRNA-derived small RNAs mediated the association between benzo[a]pyrene exposure with lung cancer risk among Chinese adults from a case-control studyYang Xiao, Chenliang Liu, Xin Guan, et al.
Cancer Medicine|June 7, 2016
Copy-number variation of MCL1 predicts overall survival of non-small-cell lung cancer in a Southern Chinese populationJieyun Yin, Yangkai Li, Hao Zhao, et al.
Cancer Science|September 8, 2018
Inhibition of kinesin family member 20B sensitizes hepatocellular carcinoma cell to microtubule-targeting agents by blocking cytokinesisXinran Liu, Yangkai Li, Xia Zhang, et al.
Molecular Carcinogenesis|October 30, 2013
Genetic variant rs16430 6bp > 0bp at the microRNA-binding site in TYMS and risk of sporadic breast cancer risk in non-Hispanic white women aged ≤ 55 yearsXiaoxiang Guan, Hongliang Liu, Jingfang Ju, et al.
Cell Death & Disease|May 12, 2018
Reducing protein regulator of cytokinesis 1 as a prospective therapy for hepatocellular carcinomaXinran Liu, Yangkai Li, Lijing Meng, et al.
Pageof 5